T 0815/22 (Infant formula promoting growth/NUTRICIA) of 23.04.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T081522.20240423
- Date of decision
- 23 April 2024
- Case number
- T 0815/22
- Petition for review of
- -
- Application number
- 16781491.2
- IPC class
- A23L 33/17A23L 33/115
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- INFANT FORMULA WITH SPECIAL LIPID ARCHITECTURE FOR PROMOTING HEALTHY GROWTH
- Applicant name
- N.V. Nutricia
- Opponent name
- Société des Produits Nestlé S.A.
Fresenius Kabi Deutschland GmbH - Board
- 3.3.09
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 53(c)European Patent Convention Art 54(5)
- Keywords
- Method of treatment excluded from patentability under Article 53(c) EPC - (No)
Purpose-limited product claim under Article 54(5) EPC - (No)
Novelty over the cited prior art documents
Novelty - (No) - Catchword
- The use of an infant formula for promoting, in an infant, a postnatal growth trajectory or body development towards a growth trajectory or body development similar to those observed in human milk fed infants, does not qualify as a method of treatment by therapy under Article
53(c) EPC (Reasons 1.7 to 1.39). - Citing cases
- T 0197/24
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.